Uncategorized
How one special Pink Day helps save and support cancer patients
When Rachel Wojnilower was an undergraduate at American University in Washington, D.C., she did all kinds of activities with her Jewish sorority, Alpha Epsilon Phi. Now 36, Wojnilower has let most of them fade from memory.
But in retrospect, one in particular stands out.
That’s because about five years after graduating, Wojnilower got married and underwent genetic testing along with her husband as they both prepared for future children. They were surprised when they each tested positive as carriers of a potentially dangerous mutation, and even more so when Wojnilower learned, after additional testing, that she also carried a mutation in the BRCA1 gene.
Such mutations, which are 10 times more common among Ashkenazi Jewish men and women than among the general U.S. population, significantly elevate the risks for breast cancer and ovarian cancer, and also increase the risks for melanoma, pancreatic and prostate cancers.
Without any intervention, there was a 50-50 chance that the couple would pass down this dangerous mutation to their children. Wojnilower didn’t know what to do.
“As you can imagine, my stress and anxiety levels were through the roof,” Wojnilower recalled. “I didn’t know a single person who had ever gone through this before.”
Then she remembered one of the volunteer opportunities she had done with Alpha Epsilon Phi: a fundraising drive for Sharsheret, the national Jewish breast cancer and ovarian cancer organization.
Wojnilower reached out to Sharsheret and spoke to one of organization’s social workers, who explained more about the mutation and what measures she could take to protect her health and that of her future children. The social worker connected Wojnilower with a trained peer supporter — another young woman who had had a very similar experience.
Ultimately, Wojnilower and her husband decided to pursue pre-implantation genetic diagnosis (PGD) — a cutting-edge procedure used with in-vitro fertilization (IVF) to screen embryos. This enabled them to identify which embryos were lower-risk and thereby reduce the chances of passing on the BRCA mutation.
Wojnilower has since given birth to two healthy children, both free of the genetic mutations that she and her husband carry.
“That’s really the essence of what we do at Sharsheret, which is Hebrew for the word chain. We are connecting women, families, and communities to each other and to life-changing and, quite frankly, lifesaving resources,” said Jordana Altman, Sharsheret’s director of marketing and communications. “Whatever the issue may be, you’re not alone, and we have skilled trained professionals and a community of thousands who together form a chain of support and information.”
Sharsheret Pink Day events, like this student-run fundraiser at Binghamton University, now take place at more than 150 college campuses, Jewish day schools and companies around the world. (Courtesy of Phi Mu Chapter of Alpha Epsilon Phi at Binghamton University)
In the years since Wojnilower was a student, Sharsheret has expanded its activities on college campuses and in Jewish day schools much more widely. One centerpiece of Sharsheret’s activities on campus is Sharsheret Pink Day — an annual day in February dedicated to the cause during which students and faculty dress in pink and undertake other activities to raise awareness of the risks for breast cancer and ovarian cancer as well as Sharsheret’s critical support programs.
The goal of Pink Day is to engage young people to participate in activities that they will remember later in life so that when one of them confronts a cancer-related challenge or helps someone who is, they’ll remember the resources Sharsheret offers. This year, Sharsheret hosted Pink Day activities around the United States at college campuses, Jewish high schools and day schools.
“We are planting seeds about Sharsheret,” said Ellen Kleinhaus, Sharsheret’s regional director of education and outreach. “While today you may only need Sharsheret to better understand your risk, you or someone you love will need Sharsheret for support in the future. There isn’t a family or a community out there that is not touched by breast cancer or ovarian cancer.”
Pink Day’s origins can be traced to 2006, when a New Jersey Jewish high school organized a dedicated day for students to support Sharsheret by wearing pink and sharing resources with their parents.
“It was such a memorable part of my high school experience,” said Tzvi Solomon, one of the students who initiated Sharsheret Pink Day. “People really rallied around it.”
Solomon was so inspired by the event that when he went to Israel for his gap year, he asked peers in the United States and Israel to bring Pink Day to their schools. Now an international initiative, the program engages thousands of participants at more than 150 schools and companies globally.
“I think it’s a reflection of our community being sensitive and recognizing the importance of having an organization like Sharsheret,” said Solomon, whose young son wore a pink shirt to school on this year’s Sharsheret Pink Day.
Amanda Goldsmith, 28, has been involved with Sharsheret since her Jewish day school hosted a Pink Day. Years later, while attending New York University, Goldsmith remembered Sharsheret when her parents called her one morning to inform her that her mother had just been diagnosed with breast cancer. Goldsmith immediately turned to Sharsheret for help and information, and she referred her mother to the organization’s peer support network.
During her mother’s treatment, Goldsmith vowed that once her mother was cancer free she’d start an initiative to get college students in New York City more involved with Sharsheret. She ended up establishing a local student board for the organization in New York City.
On Sharsheret Pink Day last year, Goldsmith, a human resource professional, implemented Wear Pink at Work, where her colleagues gave a $5 donation to Sharsheret and wore pink to the office. Her family also established a new Sharsheret program for young adults called YAD: The Young Adult Corner, which helps young adults understand their loved ones’ diagnoses, provides peer support and manages a website about cancer for young adults.
“It’s really just about spreading Sharsheret’s mission because they do so much good for so many people,” said Goldsmith, whose mother is now cancer free. “Pink Day might seem like something relatively small, but it’s hugely important.”
To learn more about Sharsheret, YAD: Young ADult Caring Corner or Sharsheret Pink Day 2024, email info@sharsheret.org.
—
The post How one special Pink Day helps save and support cancer patients appeared first on Jewish Telegraphic Agency.
Uncategorized
Michigan’s El-Sayed doubles down: Israel ‘not an ally’
(JTA) — Abdul El-Sayed, the Democratic Senate nominee in Michigan, is doubling down on his view that Israel is not a U.S. ally as the Nov. 3 midterm elections draw closer.
El-Sayed, a vocal critic of Israel who faces former Republican Rep. Mike Rogers in one of the country’s most competitive Senate races, told ABC News on Monday that Israel is “not actually our friend.”
“An ally that takes your money to push you into wars you shouldn’t be fighting is not an ally,” said El-Sayed, referencing Israel’s reported lobbying of the United States to enter into a war with Iran.
He compared Israel with a friend who “keeps bumming off [your kid’s] money” and “talks about them behind their back and then gets them into fights with other friends.”
“What would you tell your kid to do with that friend? You’d probably tell them, maybe it’s not actually your friend,” he said.
El-Sayed made similar remarks in an interview with MS NOW on Thursday, saying that “the government of Israel has done nothing but use us” and “has done terrible things with our money.”
He added that he would continue to question whether Israel was an ally regardless of the outcome of Israel’s election on Oct. 27, as Prime Minister Benjamin Netanyahu, who has served as Israel’s leader for most of the past 18 years, seeks another term.
“Netanyahu is one part of it, but the Israeli military has done heinous things, like heinous things, full war crimes, genocide,” said El-Sayed. “So I think we got to just get serious about whether or not we as a country should be subsidizing that government.”
El-Sayed previously affirmed that he does not consider Israel an ally to the United States in his first bitter debate with Rogers on Oct. 8. The candidates will meet for a final debate on Wednesday.
He told MS NOW that he was “committed to the safety and security” of Jewish voters, some of whom have pressured him to moderate his views on Israel. “Now, we may have differences when it comes to Israel, but the things that unite us are a lot bigger,” he said.
This article originally appeared on JTA.org.
The post Michigan’s El-Sayed doubles down: Israel ‘not an ally’ appeared first on The Forward.
Uncategorized
Trump endorsement of Netanyahu blasted by liberal policy advocates, Democrats
(JTA) — A day after President Donald Trump endorsed Prime Minister Benjamin Netanyahu in the Israeli election eight days from now, U.S. policy analysts, Democratic lawmakers and liberal advocacy groups slammed the decision.
Trump announced his support for Netanyahu, who is running for reelection, in a Sunday Truth Social post that described the Israeli leader as “a Great Warrior Prime Minister” and a critical partner in eliminating the Iranian threat. Netanyahu has been trailing former IDF chief-of-staff Gadi Eisenkot in recent surveys.
Tali deGroot, vice president of political and digital strategy for the liberal Zionist group J Street, described Trump’s declaration as “an endorsement of endless war for Israelis,” in a statement sent to the Jewish Telegraphic Agency. She warned of “endless occupation and control of Palestinian life and land, and Israel’s growing isolation on the world stage.”
“The president is once again acting against the wishes of American taxpayers and choosing to uphold a failed, unpopular foreign policy that has brought devastation to Israelis, Palestinians and countless civilians,” deGroot added.
A spokesperson for the American Israel Public Affairs Committee, meanwhile, said that the lobby had no comment about the endorsement.
David Makovsky, director of the Program on Arab-Israel Relations at the Washington Institute for Near East Policy, criticized Trump’s decision, writing on X that “in one fell swoop, Trump has broken with the longstanding U.S. practice of avoiding explicit endorsements in Israeli elections.” The president, Makovsky added, went a step further by threatening to sever a partnership against Iran if Israelis choose a different leader.
“It is up to the Israeli people to choose their own leader and threatening that the U.S. will walk away from the conflict with Iran is beyond stunning,” Makovksy said.
Makovsky also pointed out that “a Trump endorsement is no electoral guarantee,” noting that Trump and Vice President JD Vance’s support for Viktor Orbán in Hungary did not end in a victory.
“The ultimate test is assembling a 61-seat Knesset majority,” Makovsky added. “Yet Netanyahu appears more focused on preventing an Eisenkot-led coalition from reaching that threshold than on demonstrating a viable path to 61 seats himself.”
Sen. Chris Van Hollen, a Democrat from Maryland, offered another scathing perspective, observing that “authoritarians of a feather flock together.”
“They started a war together,” Van Hollen stated. “They crack down on press freedom together. They lie about everything together.”
Rep. Analilia Mejia, a New Jersey Democrat running for reelection, said that the endorsement “tells us everything we need to know about both of these men.” She then went on to list Netanyahu, North Korea leader Kim Jong Un, Orbán and Russian President Vladimir Putin, adding that “this guy has a ‘type.’”
On the other side of the aisle, Rep. Carlos Gimenez, a Republican from Florida, reposted a video in which Netanyahu thanked Trump for his support. The congressman then added that “America will always stand with the Jewish State of Israel and our dear friend Prime Minister Netanyahu, who has championed our alliance for decades.”
Matt Brooks, CEO of the Republican Jewish Coalition, said he believes that “President Trump is incredibly popular with the people of Israel,” in a written statement to JTA.
“His support will carry considerable weight as Israelis make their choice for Prime Minister in a pivotal election this month,” Brooks added.
American Orthodox Rabbi Shmuley Boteach likewise celebrated the endorsement “by our great President Trump,” writing on X that he has “known and loved BIBI Netanyahu for some 35 years.”
Conservative radio personality Mark Levin described Trump’s Truth Social post as “an extraordinarily strong statement,” while accusing the opposition of “barking about election interference.”
“Trump makes clear it’s also in our national security interest for Netanyahu to remain PM,” Levin stated, calling complaints “unserious and a partisan political whine.”
Conservative influencer Evan Kilgore, on the other hand, fumed at Trump’s decision. Kilgore, whose X profile says “Christ is King,” announced that he is “so done with the GOP,” following Trump’s endorsement of Netanyahu. Kilgore described Trump as “TOTALLY fu*king subverted by Jewish and Zionist interests.”
Political analysts are divided as to whether Trump’s official support would have any sway on the results of an election 6,000 miles away.
Joyce Karam, editor-in-chief of the Washington-based site Al-Monitor, described the endorsement as a signal to both Israel and Iran that renewed escalation and a push for regime collapse could occur after the U.S. midterm elections. She also predicted that Trump’s backing could tip the balance in a tight race where neither side holds a majority.
However, Dov Waxman, director of the Israel Studies program at the University of California, Los Angeles, expressed doubt that support from Trump, who has become less popular in Israel, could significantly influence Netanyahu’s election chances.
“For a long time, most polls have shown his bloc falling well short of a parliamentary majority,” Waxman added.
This article originally appeared on JTA.org.
The post Trump endorsement of Netanyahu blasted by liberal policy advocates, Democrats appeared first on The Forward.
Uncategorized
Macklemore’s ‘Free Palestine’ tour will benefit group that called Oct. 7 a ‘prison break’
(JTA) — Macklemore, the rapper of hits such as “Thrift Shop” and “Can’t Hold Us,” is facing backlash from Jewish organizations over plans to donate proceeds from his forthcoming concert tour to the Palestinian Youth Movement, which described the Hamas-led Oct. 7 attacks on Israel as a “prison break.”
The rapper was dropped on Sept. 14 from an opening slot on Ed Sheeran’s U.S. stadium tour after making pro-Palestinian remarks onstage. He announced his “Free Palestine” tour on Sept. 24, pledging that all proceeds would benefit organizations supporting Palestinians. PYM is among 12 organizations named as beneficiaries.
The tour includes concerts in Dublin on Oct. 26, Paris on Oct. 29 and London on Oct. 30.
Macklemore received a surge of support after being dropped from Sheeran’s tour, with all of Sheeran’s remaining opening acts quitting in solidarity. He said on Instagram that the “Free Palestine” tour “sold out immediately.”
PYM is a grassroots movement of Palestinian and Arab youth in the United States, Canada and Britain. On Oct. 7, 2024, the first anniversary of the Hamas attacks, the group described the assault as a “prison break” and called the fighters “the men who broke through” in an essay published in The New Inquiry.
“Those fighters had trained for months, and now found themselves stepping foot onto the same hills and plains that their grandfathers and grandmothers had lived upon,” said PYM, without mentioning the killing and abduction of Israeli civilians.
PYM also said a week after the attacks, “Understand Palestinian resistance as fundamentally just and as a means of survival for our people; it will not stop in the weeks and months to come, and you must be prepared not to waver again.”
Jewish and pro-Israel groups have slammed Macklemore for supporting PYM. The Jewish Leadership Council, which represents British Jewish and pro-Israel groups, told The Jewish Chronicle, “When the PYM describes the 7 October massacre as a ‘prison break’, it risks legitimizing violence against Jews.”
The Israeli-American Council, which petitioned Sheeran to drop Macklemore, told Fox News Digital that “Live Nation and the concert organizers must now publicly explain their vetting process and ensure that concert proceeds do not benefit organizations that justify violence against innocent civilians.”
Macklemore, Live Nation and the Palestinian Youth Movement did not immediately respond to requests for comment.
This article originally appeared on JTA.org.
The post Macklemore’s ‘Free Palestine’ tour will benefit group that called Oct. 7 a ‘prison break’ appeared first on The Forward.
